Summary

The South & Central America fill finish manufacturing market was valued at US$ 403.07 million in 2022 and is expected to reach US$ 731.41 million by 2030; it is estimated to grow at a CAGR of 7.7% from 2022 to 2030.

Significant Pipeline for Biologics Fuels South & Central America Fill Finish Manufacturing Market

Aseptic processing will need coordination, risk management, and regulatory compliance as the fill-finish industry grows quickly. In biologics, fill-finish manufacturing is essential to maintaining product integrity, sterility, and regulatory compliance. The potential for biosimilars to reduce biologic medicine costs and improve patient access to care. Biosimilars will open new avenues for innovation and scientific advancement. Therefore, a sizable biologics pipeline raises the need for fill-finish manufacturing and possibly creates opportunities. In terms of authorized follow-up biological drugs, Brazil ranks fourth globally. As of May 2023, the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved 52 follow-on biological medications and about 30 biological products that are either undergoing testing or have already undergone testing.

South & Central America Fill Finish Manufacturing Market Overview

Brazil is the fifth largest country globally by area and population and is experiencing the fastest demographic aging as well as huge cases of noncommunicable diseases (NCD), which is expected to offer massive growth opportunities for the market growth in the coming years. For instance, per the World Health Organization, in 2023, NCDs are estimated to account for 74% of all deaths. To accommodate higher demand projections and increased volume, a new greenfield aseptic fill/finish site was designed due to regulatory pressures on the current facility. In addition, the project instituted advanced aseptic processing in Brazil. Therefore, the rise in strategic initiatives is expected to fuel the market for fill finish manufacturing in the country during the forecast period.

South & Central America Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Fill Finish Manufacturing Market Segmentation

The South & Central America fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the South & Central America fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the South & Central America fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

By end user, the South & Central America fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the South & Central America fill finish manufacturing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America fill finish manufacturing market share in 2022.

Becton Dickinson and Co, Gerresheimer AG, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the South & Central America fill finish manufacturing market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Fill Finish Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
5. South & Central America Fill Finish Manufacturing Market - Key Industry Dynamics
5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
5.2.2 Elevating Demand for Biologics
5.3 Key Market Restraints
5.3.1 Complexity in Biologics Manufacturing
5.4 Key Market Opportunities
5.4.1 Significant Pipeline for Biologics
5.5 Key Future Trends
5.5.1 Single-Use Systems for Aseptic Fill Finish
5.6 Impact of Drivers and Restraints:
6. Fill Finish Manufacturing Market - South & Central America Market Analysis
7. South & Central America Fill Finish Manufacturing Market Analysis - Product
7.1 Consumables
7.1.1 Overview
7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Fill Finish Manufacturing Market Analysis - Modality
8.1 Recombinant Proteins
8.1.1 Overview
8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Monoclonal Antibodies
8.2.1 Overview
8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Vaccines
8.3.1 Overview
8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Cell Therapies and Biological Therapies
8.4.1 Overview
8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Gene Therapies
8.5.1 Overview
8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Fill Finish Manufacturing Market Analysis - End User
9.1 Contract Manufacturing Organizations
9.1.1 Overview
9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Fill Finish Manufacturing Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
10.1.1.1 Brazil
10.1.1.2 Brazil Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.2.1 Brazil Fill Finish Manufacturing Market Breakdown by Product
10.1.1.2.1.1 Brazil Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.2.2 Brazil Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.2.3 Brazil Fill Finish Manufacturing Market Breakdown by End User
10.1.1.3 Argentina
10.1.1.4 Argentina Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.4.1 Argentina Fill Finish Manufacturing Market Breakdown by Product
10.1.1.4.1.1 Argentina Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.4.2 Argentina Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.4.3 Argentina Fill Finish Manufacturing Market Breakdown by End User
10.1.1.5 Rest of South & Central America
10.1.1.6 Rest of South & Central America Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.6.1 Rest of South & Central America Fill Finish Manufacturing Market Breakdown by Product
10.1.1.6.1.1 Rest of South & Central America Fill Finish Manufacturing Market Breakdown by Consumables
10.1.1.6.2 Rest of South & Central America Fill Finish Manufacturing Market Breakdown by Modality
10.1.1.6.3 Rest of South & Central America Fill Finish Manufacturing Market Breakdown by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 IMA Industria Macchine Automatiche SpA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Nipro Medical Europe NV
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Maquinaria Industrial Dara SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SGD SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Optima Packaging Group Gmbh
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Stevanato Group SpA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Syntegon Technology GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 West Pharmaceutical Services Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Gerresheimer AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Schott AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Becton Dickinson and Co
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms